^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Camcevi 42 mg (leuprolide 6-month depot)

    i
    Other names: FP-001 42 mg, FP-001 LMIS
    Company:
    Foresee Pharma, GeneScience, Intas
    Drug class:
    GnRH agonist
    Related drugs:
    5ms
    Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty (clinicaltrials.gov)
    P3, N=93, Active, not recruiting, Foresee Pharmaceuticals Co., Ltd. | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    Camcevi 42 mg (leuprolide 6-month depot)
    10ms
    Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects with Central Precocious Puberty (clinicaltrials.gov)
    P3, N=93, Recruiting, Foresee Pharmaceuticals Co., Ltd. | Trial completion date: Dec 2025 --> Jun 2026
    Trial completion date
    |
    Camcevi 42 mg (leuprolide 6-month depot)